Daily non-political popular news in brief.

NIAID scientists identify new cellular receptor for HIV

A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Read more »

Keywords: niaid, scientists, identify, cellular, receptor, hiv, scientist

« Previous | Next »

Similar news on "NIAID scientists identify new cellular receptor for HIV":

1. UCSD researchers identify critical receptor in liver regeneration
   03-29-2007 · EurekAlert!
   In studies in mouse models, researchers at the University of California, San Diego (UCSD) School of Medicine have found that a cellular receptor involved in triggering cell death is also a necessary component of tissue repair and regeneration immediately following liver injury. This discovery could have implications for early intervention or therapy in liver disease such as cirrhosis or hepatitis.
   Similar news · Read more »
   
2. NIAID scientists identify human protein that helps chickenpox and shingles virus spread
   10-19-2006 · EurekAlert!
   A team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has identified a human protein that helps varicella-zoster virus, the cause of chickenpox and shingles, spread from cell to cell within the body.
   Similar news · Read more »
   
3. Researchers identify protein pathway involved in Parkinson disease development
   06-18-2007 · EurekAlert!
   Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease.
   Similar news · Read more »
   
4. The quest for an effective HIV vaccine presents new possibilities, challenges
   05-16-2007 · EurekAlert!
   A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at NIAID. Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce HIV levels in the body, thereby delaying the progression to AIDS and the need to start antiretroviral drugs.
   Similar news · Read more »
   
5. HIV persists in the gut despite long-term HIV therapy
   02-13-2008 · EurekAlert!
   Because of the importance of the gut to HIV disease, scientists hoped that long-term treatment with antiretroviral drugs could eradicate HIV from the GALT. A new NIAID study, published online by The Journal of Infectious Diseases, has found that this goal seems unlikely with current antiretroviral drugs.
   Similar news · Read more »
   
6. Scientists unveil piece of HIV protein that may be key to AIDS vaccine development
   02-14-2007 · EurekAlert!
   In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the NIAID have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody. Unlike much of the constantly mutating virus, this protein component is stable and -- more importantly, say the researchers -- appears vulnerable to attack from this specific antibody, known as b12, that can broadly neutralize HIV.
   Similar news · Read more »
   
7. Scientists identify protein that may promote migraines
   03-08-2007 · EurekAlert!
   A University of Iowa study may provide an explanation for why some people get migraine headaches while others do not. The researchers found that too much of a small protein called RAMP1 appears to "turn up the volume" of a nerve cell receptor's response to a neuropeptide thought to cause migraines.
   Similar news · Read more »
   
8. Scientists identify embryonic stem cells by appearance alone
   08-27-2007 · EurekAlert!
   Scientist can now identify pluripotent stem cells based solely on their physical appearance.
   Similar news · Read more »
   
9. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
   07-16-2007 · EurekAlert!
   UCLA scientists, along with collaborators from Purdue University, have demonstrated that HIV protease inhibitors -- crucial drugs for HIV treatment -- block a cellular enzyme important for generating the structural scaffolding for the cell nucleus. The findings may offer insight into the side effects of HIV protease inhibitors.
   Similar news · Read more »
   
10. Novel vaccine concept developed by scientists at the Wistar Institute
    01-31-2008 · EurekAlert!
    A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
    Similar news · Read more »